RN2 Technologies Co

RN2 Technologies Co Forward P/E

The Forward P/E Ratio of RN2 Technologies Co (148250.KQ) as of Nov 6, 2026 is -7.43. In the previous year, Forward P/E Ratio was -16.71 — a change of -55.53% (higher).

Forward P/E

-7.43

YoY

-55.53%

Last updated:

Forward P/E Ratio of RN2 Technologies Co is 2025 -7.43 . Forward P/E Ratio of RN2 Technologies Co was 2024 -16.71 . It decreases by -55.53% higher compared to the previous year.

The RN2 Technologies Co Forward P/E history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Forward P/E
Date
Forward P/E
Jan 1, 2018
29.77 KRW
Jan 1, 2019
31.61 KRW
Jan 1, 2020
7.26 KRW
Jan 1, 2021
18.33 KRW
Jan 1, 2022
-240.68 KRW
Jan 1, 2023
-7.79 KRW
Jan 1, 2024
-16.71 KRW
Jan 1, 2025
-7.43 KRW
The RN2 Technologies Co Forward P/E history
YEARForward P/EYoY
-7.43-55.53%
-16.71+114.47%
-7.79-96.76%
-240.68-1,412.87%
18.33+152.56%
7.26-77.04%
31.61+6.19%
29.77-19.48%
36.97+58.68%
23.30+37.62%
16.93-5.62%
17.94—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

RN2 Technologies Co Stock analysis

What does RN2 Technologies Co do? RN2 Technologies Co., Ltd. generates revenue through three business segments: component, substrate, and material. The component segment sells couplers, delay lines, and terminations to the communication industry. The substrate segment offers LTCC substrates and foundry services for medical image diagnosis devices and manufacturing device development. The material segment produces LTCC powders for high and low dielectric applications in communication devices. Domestic and international markets are the primary sales channels for all segments. The company's products target communication infrastructure providers, medical device manufacturers, and electronics developers. Communication industry clients purchase couplers and terminations for network equipment. Medical device companies use LTCC substrates for imaging systems. Electronics firms source LTCC powders for component manufacturing. All segments serve both local Korean customers and global clients. RN2 Technologies' revenue streams are directly tied to component sales for telecom networks, substrate services for medical imaging, and material supply for communication device production. The company's product portfolio aligns with industry needs in telecommunications, healthcare technology, and electronics manufacturing. No additional segments or revenue sources are mentioned in the business description. RN2 Technologies Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about RN2 Technologies Co stock

Forward P/E Ratio of RN2 Technologies Co is -7.43 in 2025.

Forward P/E Ratio of RN2 Technologies Co changed from -16.71 to -7.43, representing a -55.53% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Forward P/E Ratio RN2 Technologies Co since 2006 – with annual values, charts, and detailed analysis.

The Forward P/E uses estimated future earnings to value a stock. A lower forward P/E relative to the trailing P/E suggests analysts expect earnings growth.

To evaluate Forward P/E Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Forward P/E Ratio.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Forward P/E Ratio's RN2 Technologies Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — RN2 Technologies Co

All Key Metrics — RN2 Technologies Co